Clinical trials
Phase 1/2 Fallopian Tube Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 23andMe, Inc. | 1 |
| ImmunoGen, Inc. | 1 |
| ImmunoVaccine Technologies, Inc. (IMV Inc.) | 1 |
| Imunon | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Mundipharma Research Limited | 1 |
| Pfizer | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| University Health Network, Toronto | 1 |
| pharmaand GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 10 |
| Carcinoma, Ovarian Epithelial | 6 |
| Ovarian Neoplasms | 6 |
| Carcinoma, Renal Cell | 3 |
| Recurrence | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.